Task: Please answer the following question about the molecule with SMILES CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC.
Request: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Completion: Phase 3 Clinical Trials
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC
CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC
4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.